Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan/HDS in Metastatic Breast Cancer with Liver Dominant Disease
NCT06875128Phase 2Recruiting
- Sponsor
- Delcath Systems
- Start
- Jan 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of melphalan in breast cancer, sponsored by Delcath Systems. Started Jan 2026; status: recruiting.
02
Drugs
melphalan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06875128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06875128.